Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Published on by Health Scientists

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.

Siyu Chen | Pharmacology | Best Researcher Award

Published on by Health Scientists

 Prof. Siyu Chen | Pharmacology | Best Researcher Award

Professor | China Pharmaceutical University | China

Dr. Chen Siyu currently serves as the Deputy Director of the Department of Biochemistry at the School of Life Sciences and Technology, China Pharmaceutical University, where he is also a Professor, Doctoral Supervisor, and Chief Young Scientist of the National Key Research and Development Program. He obtained his academic training in biochemistry and molecular biology, cultivating a strong foundation in metabolic and biochemical sciences. Dr. Chen’s research primarily focuses on Target Discovery and Intervention Strategies for Metabolic Diseases, aiming to elucidate molecular mechanisms and identify novel therapeutic targets for metabolic regulation. He has published extensively as first or corresponding author in leading international journals such as Advanced Science, Nature Communications, and Gut Microbes, with his work widely cited by peers. His innovative research has led to the granting of national patents and multiple ongoing patent applications. Dr. Chen has successfully led major research projects under national and provincial funding programs, including the National Key R&D Program for Young Scientists, the National Natural Science Foundation for Young Scientists, and the Jiangsu Province Excellent Youth Fund. Recognized for his scholarly excellence, he received the Outstanding Doctoral Dissertation Award of Jiangsu Province. In addition to his research, Dr. Chen contributes actively to the academic community as a Young Member of the Metabolism Committee of the Chinese Society of Biochemistry, Director of the Jiangsu Society of Developmental Biology, and Editorial Board Member of Journal of China Pharmaceutical University and Progress in Biochemistry and Biophysics. He also serves as a Guest Editor for Frontiers in Endocrinology and a regular reviewer for leading journals including Journal of Hepatology and ACS Nano. He has 1616 citations from 60 documents with an h-index of 24.

Profiles: Scopus | ORCID

Publications

1. Photosensitive biomimetic nanomedicine-mediated recombination of adipose microenvironments for antiobesity therapy. (2025). Advanced Materials.

2. Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity. (2025). Bioengineering and Translational Medicine.

3. Blue light-driven cell cycle arrest in thyroid cancer via Retinal-OPN3 complex. (2024). Cell Communication and Signaling.

4. Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. (2024). EMBO Molecular Medicine.

5. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. (2024). Phytomedicine.

Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Assistant Professor | Shahid Beheshti University of Medical Sciences | Iran

Dr. Milad Rahimzadegan is an Assistant Professor at the Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, and serves as R&D Manager in multiple pharmaceutical companies. He earned his PhD in Pharmacy-Toxicology and Pharmacology from Tehran University of Medical Sciences, followed by an M.Sc. in Medical Toxicology from Tarbiat Modares University, and a B.A. in Plant Medicine from the University of Tehran. Recently, he completed a post-doctoral fellowship focused on Artificial Intelligence in Neuroscience at the Functional Neurosurgery Research Center. Dr. Rahimzadegan’s research spans neuropharmacology, neurotoxicology, regenerative medicine, and advanced drug delivery systems, with particular emphasis on stem cell differentiation, conductive scaffolds for spinal cord injury, and nano-biosensing for cardiovascular and neurodegenerative diseases. He has authored numerous high-impact publications in journals including Stem Cell Reviews and Reports, International Journal of Biological Macromolecules, Materials Science & Engineering C, and Carbohydrate Polymers, and has contributed to multiple books on pharmacology, regenerative medicine, and neurosurgery. His work has been recognized with awards such as the Top Academic Secretary of USERN Iran, Young Scientific Award at Shahid Beheshti University, and membership in Iran’s National Elites Foundation. In addition to his research contributions, he serves as a reviewer and editorial board member for journals including Interventional Pain Medicine and Neuromodulation and International Clinical Neuroscience Journal, reflecting his commitment to advancing scientific knowledge and fostering innovation in neuroscience, pharmacology, and translational medicine. He has 326 citations from 26 documents with an h-index of 11.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Rahimzadegan, M., & Soodi, M. (2018). Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus.

2. Asl, S. K., & Rahimzadegan, M. (2022). The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.

3. Malek-Khatabi, A., Razavi, M. S., Abdollahi, A., & Rahimzadeghan, M., et al. (2023). Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery.

4. Asl, S. K., Rahimzadegan, M., & Asl, A. K. (2024). Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

5. Asl, S. K., Rahimzadegan, M., & Ostadrahimi, R. (2024). The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction.

Sina Andalib | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Sina Andalib | Pharmacology | Best Researcher Award

correspond author | Zanjan university of medical sciences | Iran

Dr. Sina Andalib is an Associate Professor at the Department of Pharmacology, Pharmacy Faculty, Zanjan University of Medical Sciences, Iran. He earned his Doctor of Veterinary Medicine (DVM) from Tabriz Azad University in 2005, focusing on anti-inflammatory effects of statins, and completed his PhD at Tabriz University of Medical Sciences in 2013, investigating the cardioprotective effects of Atorvastatin in isoproterenol-induced heart failure in rats. Dr. Andalib’s research spans pharmacology, neurodegenerative diseases, drug delivery systems, and natural product therapeutics, with a particular focus on Alzheimer’s disease, Parkinson’s disease, diabetes, and cancer. He has supervised numerous PhD and PharmD theses exploring innovative nanoparticle-based drug delivery, herbal and synthetic compound interventions, and molecular mechanisms underlying neuroprotection and cardioprotection. His work has been published extensively in high-impact international journals including ACS Chemical Neuroscience, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, and European Journal of Pharmacology, covering topics such as nanocomposite hydrogels for wound healing, fullerene-based interventions in Alzheimer’s models, and polypharmacological effects of anticancer compounds. Dr. Andalib has contributed to several internationally collaborative projects, including the development of nanocomposites for neuroprotection and polypharmacological studies of anticancer compounds in organoid models. He has received recognition for his scientific contributions in pharmacology and neurotherapeutics and serves on editorial boards of peer-reviewed journals in pharmacology and drug delivery research. In addition to his research, he holds leadership roles at Zanjan University, including Head of the Department of Pharmacology and Toxicology and Head of the Education Development Office, fostering academic development and innovative research in pharmaceutical sciences. He has 751 citations from 39 documents with an h-index of 15.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Danafar, H., Sharafi, A., Kheiri Manjili, H., & Andalib, S. (2017). Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells.

2. Garjani, A., Fathiazad, F., Zakheri, A., Akbari, N. A., Azarmie, Y., Fakhrjoo, A., et al. (2009). The effect of total extract of Securigera securidaca L. seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats.

3. Barzegar-Jalali, M., Alaei-Beirami, M., Javadzadeh, Y., Mohammadi, G., et al. (2012). Comparison of physicochemical characteristics and drug release of diclofenac sodium–eudragit® RS100 nanoparticles and solid dispersions.

4. Garjani, A., Andalib, S., Biabani, S., Soraya, H., Doustar, Y., & Garjani, A., et al. (2011). Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.

5. Abedimanesh, N., Asghari, S., Mohammadnejad, K., Daneshvar, Z., et al. (2021). The anti-diabetic effects of betanin in streptozotocin-induced diabetic rats through modulating AMPK/SIRT1/NF-κB signaling pathway.

Amin Hasanvand | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Amin Hasanvand | Pharmacology | Best Researcher Award

Associate Professor | Lorestan University | Iran

Dr. Amin Hasanvand, Associate Professor in the Department of Pharmacology at Lorestan University of Medical Sciences, is an accomplished Iranian pharmacologist and biomedical scientist whose career reflects excellence in research, teaching, and leadership in health sciences. He earned his Ph.D. in pharmacology from Tehran University of Medical Sciences in 2016, with a doctoral thesis focused on the AMPK signaling pathway and its role in diabetic neuropathy, and has since developed a robust academic profile. His research interests span pharmacology, diabetes, nephropharmacology, inflammation, neuropathy, and neuroscience, with particular focus on AMPK-dependent mechanisms, metformin, gut microbiome modulation, and novel strategies for neuropathic pain management. Over the years, Dr. Hasanvand has published more than 50 peer-reviewed articles in SCI and Scopus-indexed journals, authored two academic books titled Medical Pharmacology Education and Antibiotics: Mechanisms of Action and Clinical Applications, and contributed to over 40 completed research projects, while actively mentoring medical and pharmacy students. He also serves as Editor of the Herbal Medicine Journal and as an editorial board member of Annals of Pharmacology and Immunopathologia Persa, alongside being a reviewer for leading international journals such as Journal of Neuroimmune Pharmacology, Cancer Control, and Obesity Reviews. In recognition of his impactful contributions, Dr. Hasanvand has been honored seven times as the top researcher at his university and was ranked among the world’s top 2% most influential scientists in 2023. His distinguished career reflects an enduring commitment to advancing pharmacological sciences and improving health outcomes through research, innovation, and education. He has 809 citations from 38 documents with an h-index of 14.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Mir, S., Abbaszadeh, A., Hasanpour Dehkordi, A., & Hasanvand, A. (2019). Metformin and its anti-inflammatory and anti-oxidative effects; new concepts. Journal of Renal Injury Prevention.

2. Hasanvand, A., Kharazmkia, A., Mir, S., Khorramabadi, R. M., & Darabi, S. (2018). Ameliorative effect of ferulic acid on gentamicin-induced nephrotoxicity in a rat model; role of antioxidant effects. Journal of Renal Injury Prevention.

3. Khorramabadi, R. M., Amanolahi Baharvand, P., Pirzadroozbahani, N., Hasanvand, A., Kharazmkia, A., Goudarzi, M., Mir, S., & Ahmadizar, F. (2018). Evaluation of the antioxidant effects of zolpidem in the rat model of cisplatin-induced nephrotoxicity. Journal of Renal Injury Prevention.

4. Hasanvand, A., Amini-Khoei, H., Jahanabadi, S., Hadian, M.-R., Abdollahi, A., Tavangar, S. M., Mehr, S. E., & Dehpour, A. R. (2018). Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through activation of AMPK signaling pathway. Journal of Nephropathology.

5. Abbaszadeh, A., Koushki, S., Koushki, S., Eskandarzadeh, M., & Hasanvand, A. (2018). Metformin; a mini-review to its antioxidative and anti-inflammatory properties. Journal of Renal Injury Prevention.

6. Babaeenezhad, E., & Hasanvand, A. (2018). Renoprotective impacts of metformin with insulin in type 1 diabetes; role of its antioxidant efficacy. Journal of Nephropathology.

Paramanna Poojari | Pharmacology | Best Researcher Award

Published on by Health Scientists

Mr. Paramanna Poojari | Pharmacology | Best Researcher Award

Research Scholar | Karnatak University Dharwad | India

Dr. Paramanna Poojari, currently serving as a Research Scholar in the Department of Biochemistry at Karnatak University Dharwad, has built a strong academic and professional foundation in the fields of biochemistry, microbiology, nanotechnology, and cell culture. He holds a postgraduate degree in biochemistry and has specialized in experimental and applied research with a focus on nanoscience, cancer biology, drug delivery systems, and phytoremediation. Dr. Poojari’s research explores the potential of nanoparticles, plant tissue culture, antibiotic sensitivity testing, and nanomaterial characterization, with the objective of advancing innovative solutions for healthcare, pharmaceuticals, and environmental sustainability. His scholarly contributions include publications in highly regarded international journals indexed in Scopus, Google Scholar, and UGC CARE list, such as Drug Delivery Science and Technology, Water Air and Soil Pollution, and Dispersion Science and Technology, with a citation index of 24 and an h-index of 3. He has also contributed a book chapter published with ISBN: 9781032699882, further strengthening his academic profile. In recognition of his growing expertise, Dr. Poojari has been entrusted with editorial and peer-review responsibilities for reputed publishers including Elsevier and Springer Nature, underscoring his role in maintaining research quality and scientific integrity. His collaborations with nanotechnology laboratories have enabled interdisciplinary exploration bridging life sciences and material sciences. With patents under preparation and continued innovation in biotechnology applications, Dr. Poojari exemplifies a dedicated young scientist committed to impactful research. His academic achievements and professional contributions highlight his potential as a future leader in health sciences and allied fields. He has 18 citations from 8 documents with an h-index of 3.

Profile: Google Scholar | Scopus | ORCID

Publications

1. Ganeshkar, M. P., Gaddigal, A. T., Shivappa, P., Poojari, P. B., Goder, P. H., … (2023). Biocompatibility assessment of Rutin and PEG loaded novel nanoceria on human erythrocytes and human myeloid leukemia (U937) cells. Journal of Drug Delivery Science and Technology, 86, 104761.

2. Gaddigal, A. T., Shivappa, P., Ganeshkar, M. P., Mirjankar, M. R., Poojari, P. B., … (2024). Green synthesis of copper oxide nanoparticles using Simarouba glauca leaf extract, characterization and screening for their biological applications. Journal of Dispersion Science and Technology, 1–15.

3. Mirjankar, M. R., Pattar, S. V., Gaddigal, A. T., Shivappa, P., Poojari, P. B., … (2023). Phytoremediation of copper contaminated water using Pistia stratiotes and emphasis of thermal stability in response to metal stress. Water Conservation Science and Engineering, 8(1), 24.

4. Mirjankar, M. R., Pattar, S. V., Gaddigal, A. T., Shivappa, P., Poojari, P. B., … (2023). Isolation of culturable endophytic bacteria from the roots of Aloe vera L. (Aloe barbadensis Miller) and their application in phytodegradation of xenobiotics. Water, Air, & Soil Pollution, 234(7), 451.

5. Shivappa, P., Mirjankar, M. R., Gaddigal, A. T., Ganeshkar, M. P., Poojari, P. B., … (2023). Bismuth nanoparticle synthesis utilizing hydroalcoholic Endocomia macrocoma leaf extract to evaluate their antimicrobial, antioxidant, and anticancer properties. Journal of Dispersion Science and Technology, 1–15.